TFRC and breast cancer: The protein-based thermosensitive nanoplatform was characterized by its profound accumulation and penetration in tumor sites, which was recognized by TFR-mediated endocytosis in breast cancer cells (Figure 3A,D) and the significant tumor accumulation of TMNPs in 4T1 tumor-bearing mouse model (Figure 4).